DOSSIER · 13F-HR · Q2 2026

Ishara Investments LP

$136M in tracked AUM across 41 positions as of Q2 2026.

II
CIK 0002111609 · last filed Jun 30, 2026
Total AUM
$136M
as of Q2 2026
Holdings
41
positions
Whale Score
56
56
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Ishara Investments LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
ACAD
ACADIA PHARMACEUTICALS INC
$10M410K7.6%
02
XERS
XERIS BIOPHARMA HOLDINGS INC
$10M1.2M7.2%
03
BMRN
BIOMARIN PHARMACEUTICAL INC
$8M144K6.0%
04
PRAX
PRAXIS PRECISION MEDICINES I
$8M23K5.5%
05
RARE
ULTRAGENYX PHARMACEUTICAL IN
$7M205K5.0%
06
AGIO
AGIOS PHARMACEUTICALS INC
$6M164K4.5%
07
INSM
INSMED INC
$5M51K4.0%
08
CRNX
CRINETICS PHARMACEUTICALS IN
$5M144K3.9%
09
ZNTL
ZENTALIS PHARMACEUTICALS INC
$5M1.0M3.7%
10
PCVX
VAXCYTE INC
$5M82K3.5%

Filing history

2026Q2Jun 30
$136M 28.9%
41 positionsView →
2026Q1Mar 31
$106M 20.8%
37 positionsView →
2025Q4Dec 31
$87M
38 positionsView →